Professor Andrew Godkin
Prosiectau fel Prif Ymchwiliwr
- Identifying biomarkers to predict response to immunotherapies (01.06.2017 - 30.09.2017)
- ImmuScreen (01.07.2019 - 31.08.2022)
- Louise Lambert PhD Scholarship (01.01.2022 - 31.12.2025)
- Natural killer cell activation by IL-10 superfamily implications for HCV (01.07.2012 - 11.08.2012)
- Phase 1 COVID-19 Immunity – National Core Study (Phase 1 IMM- NCS (01.04.2021 - 30.09.2022)
Prosiectau fel Cyd-Ymchwiliwr
- Biomedical Vacation Scholarships (01.07.2009 - 01.09.2009)
- Cardiff University Infection and Immunity Annual meeting 2022 (01.09.2022 - 17.02.2023)
- Coordinating COVID-19 asymptomatic testing programmes in university settings: providing insight on acquired immunity across the student population (01.01.2021 - 31.03.2021)
- Deciphering the molecular rules that govern CD4+ T cell responses to tumour associated antigen peptides to enhance anti-tumour immunity through neo-modification (01.10.2022 - 31.03.2025)
- Development of bespoke T cell-inducing adenovirus-based vaccine vectors (01.08.2022 - 31.03.2023)